about
Pharmacological interventions for preventing recurrent urinary stones in adults and childrenAlpha-blockers as medical expulsive therapy for ureteral stonesPharmacological interventions for preventing recurrent urinary stones in adults and childrenAlpha-blockers as medical expulsive therapy for ureteral stonesPrevention of renal crystal deposition by an extract of Ammi visnaga L. and its constituents khellin and visnagin in hyperoxaluric ratsAntiurolithic activity of Origanum vulgare is mediated through multiple pathwaysStudy of quality of life and its determinants in patients after urinary stone fragmentation.Prevention of stone disease.Surgical management of bladder stones: literature review.Potential Mechanisms Responsible for the Antinephrolithic Effects of an Aqueous Extract of Fructus Aurantii.Role of silodosin as medical expulsive therapy in ureteral calculi: a meta-analysis of randomized controlled trials.Studies on the in vitro and in vivo antiurolithic activity of Holarrhena antidysenterica.Laboratory assessment.Pathophysiology and clinical aspects of urinary lithiasis.Effect of urine pH on the effectiveness of shock wave lithotripsy: A pilot study.Calcium Oxalate Induces Renal Injury through Calcium-Sensing Receptor.Herbal medicines in the management of urolithiasis: alternative or complementary?Medical expulsive therapy.Antiurolithiasis Activity of Bioactivity Guided Fraction of Bergenia ligulata against Ethylene Glycol Induced Renal Calculi in RatBryophyllum pinnatum Leaf Extracts Prevent Formation of Renal Calculi in Lithiatic Rats.Cats and calcium oxalate: strategies for managing lower and upper tract stone disease.Urinary tract stone disease: are all problems solved?Unenhanced CT findings can predict the development of urinary calculi in stone-free patients.Aspects on how extracorporeal shockwave lithotripsy should be carried out in order to be maximally effective.Should we modify the principles of risk evaluation and recurrence preventive treatment of patients with calcium oxalate stone disease in view of the etiologic importance of calcium phosphate?Dietary management of IBD--insights and advice.Engineering Better Lithotripters.Surveillance Bias in Cancer Risk After Unrelated Medical Conditions: Example UrolithiasisMetabolic risk-evaluation and prevention of recurrence in stone disease: does it make sense?Predictive parameters for medical expulsive therapy in ureteral stones: a critical evaluation.Functional and morphological recovery of solitary kidneys after drainage. Double J stent placement vs emergency ureteroscopy: which one is reasonable?Shockwave lithotripsy: techniques for improving outcomes.Reduced time from diagnosis to stone-free status in patients with ureteral calculi.Knowledge, attitudes, and practice patterns of recurrent urinary stones prevention in Saudi Arabia.Antilithic effects of extracts from different polarity fractions of Desmodium styracifolium on experimentally induced urolithiasis in rats.Effect of medical expulsive therapy on the health-related quality of life of patients with ureteral stones: a critical evaluation.An improvement project within urological care.Protective effect of ethyl acetate fraction of Biophytum sensitivum extract against sodium oxalate-induced urolithiasis in rats.Administration of the selective alpha 1A-adrenoceptor antagonist silodosin facilitates expulsion of size 5-10 mm distal ureteral stones, as compared to control.[Urolithiasis in childhood].
P2860
Q24194727-EC8F5E42-9376-403C-89BF-AF10943AFD21Q24197512-F7C69C5F-574A-4BF7-8EF7-3E30F26C3DDFQ24202533-1188359A-C9E6-4382-920A-3D48DFA19C78Q24235652-86164C76-FB5A-4D8F-858D-77A2443BB916Q28298085-DAB2F1E8-8914-4DD6-A569-5CB6485685F3Q34049630-85115245-C7C9-4365-B18D-89304FB4B50BQ34282677-3CD82E7A-ABD3-4ABA-9C19-BA0BCD455A7BQ34668124-BF75489D-8B22-43FB-95E1-A543BFDFDC8EQ34891004-43F92D94-AD7A-4160-B5B0-C450D334D1A0Q35798094-76E427BA-8F71-4970-871D-B5DC9D380DACQ36330993-2C1AB293-6EB5-47C5-BB0D-FD3D7923BF9CQ36883722-0972D3A3-662B-4A52-A019-32236B88CF02Q36921841-CFF8EEF2-BA2A-4D8F-9A92-D376738F80C5Q36921846-EEB3523A-A46E-4889-886C-D03651198CEBQ37094271-36E88F0C-C7A9-4F3F-B749-EF7689999463Q37443747-EA0C59E7-B79A-40B8-9340-64D1384EAD6CQ37483683-E3924FC0-5CD3-4A39-928C-495D385B1009Q37498188-14CE40D8-ACDC-4B74-AF67-95C43642961EQ37703611-29EFB216-194C-4005-914B-DAA0ACE628A5Q37739735-0EC2E443-09B6-4693-9FC6-9FFE1D7DB81DQ37923104-08EB1F2C-54E6-46D0-95EC-716271A6E04AQ38006522-4590B381-BAEF-4911-9901-D8F848BF3A9DQ38008912-E5D53D3B-86D7-45CA-B891-88E5D4D40F4CQ38021962-2EFA81ED-2CBD-4A7C-9F5A-9C5C27FF61D3Q38236336-1372118E-DB20-40B8-9C83-D9938222EEB7Q38342102-951C4FA0-3981-43EE-A561-A8258F1BCA26Q38528381-AC4C9063-6BEC-4055-BED6-781CF838C4CCQ38624936-252C77F7-1B9F-4B29-B8C6-579BC4D68E23Q38650727-4E3E9385-2344-4CDC-A02B-1323DB3F6DCEQ39023969-FF1C4382-54C9-426E-9219-C77AE6C74893Q39150035-EC4335CE-07EB-4A89-8AAD-27BDA89D3C51Q39368622-EB8B29EB-DCE2-4B14-ACB1-957EA4EB4C63Q39817239-B2389CDC-6D12-49B6-8A2A-B90EB3917576Q40619090-0F48120C-CF82-499B-AB33-54A005677D33Q40783986-BB6E69EC-4BCE-4810-8F80-6D0A22CE3200Q40785740-64230923-749C-422C-AF73-263AC70F3A42Q40930790-E715AAF9-933D-40A5-A0B6-B65F1A648967Q42374021-5A6EF9F8-ED9B-42DC-93BF-EE6A7D39F1F3Q43666931-98740E39-185B-49FC-89ED-35D567152ECCQ45021650-82073D67-42E0-44E8-A1E7-EE39E198B136
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Epidemiology and medical management of stone disease.
@ast
Epidemiology and medical management of stone disease.
@en
Epidemiology and medical management of stone disease.
@nl
type
label
Epidemiology and medical management of stone disease.
@ast
Epidemiology and medical management of stone disease.
@en
Epidemiology and medical management of stone disease.
@nl
prefLabel
Epidemiology and medical management of stone disease.
@ast
Epidemiology and medical management of stone disease.
@en
Epidemiology and medical management of stone disease.
@nl
P1433
P1476
Epidemiology and medical management of stone disease.
@en
P2093
Tiselius HG
P304
P356
10.1046/J.1464-410X.2003.04208.X
P577
2003-05-01T00:00:00Z